1. gnxp
  2. In search of rare variants

In search of rare variants

By razib on April 20, 2009.

In response to the NEJM issue on personal genomics and the CDCV hypothesis, p-ter offers a proposal:

Let's follow Goldstein's back-of-the-envelope calculations: assume there are ~100K polymorphisms (assuming Goldstein isn't making the mistake I attribute to him, this includes polymorphisms both common and rare) that contribute to human height, that we've found the ones that account for the largest fractions of the variance, and that these fractions of variance follow an exponential distribution.

Now, assume you have assembled a cohort of 5000 individuals and done a genome-wide association study using common SNPs. You find some interesting things, but you want more. Now, you have two choices: sequence those 5000 individuals to look for rarer variation, or increase sample size to 20,000 and perform another association study using the same set of common polymorphisms.

Read the whole thing.

Tags
genetics
Common disease-common variant hypothesis
David Goldstein
genetic variation
Medical Genetics

More like this

Show me the data
Update: Also see p-ter at Gene Expression Classic. Follow up on yesterday's post on the new Dickson et al. paper from David Goldstein's lab, A New Way to Look for Diseases' Genetic Roots: The Icelandic gene-hunting firm deCODE genetics, which emerged last week from bankruptcy, has long led in…
Common disease-common variant hypothesis taken down a notch (again)
David Goldstein, a geneticist at Duke, has critiqued the current focus on large-scale genomwide associations before. Now he is taking to the next step, as his group has a paper out which suggests that the reason that association studies have been relatively unfruitful in terms of bang-for-buck is…
David Goldstein on the failures of genome-wide association studies
The genome-wide association study has been the technique du jour in human genetics for much of the last two years. It's a pure brute force approach, surveying up to a million sites of common variation throughout the genomes of thousands of people at a time, some of whom suffer from a particular…
Illumina delivers its first commercial personal genome sequence
Sequencing giant Illumina has announced that it has delivered its first commercial personal genome sequence. The sequence was generated by the genome sequencing service launched by Illumina back in June, and was delivered in collaboration with new personal genomics company Pathway Genomics.…